Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Toxicity of Annonaceae for dopaminergic neurons: potential role in atypical parkinsonism in Guadeloupe.

Lannuzel A, Michel PP, Caparros-Lefebvre D, Abaul J, Hocquemiller R, Ruberg M.

Mov Disord. 2002 Jan;17(1):84-90.

PMID:
11835443
2.

L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.

Ogawa N, Asanuma M, Miyazaki I, Diaz-Corrales FJ, Miyoshi K.

J Neurol. 2005 Oct;252 Suppl 4:IV23-IV31. Review.

PMID:
16222434
3.

Levodopa toxicity and apoptosis.

Melamed E, Offen D, Shirvan A, Djaldetti R, Barzilai A, Ziv I.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S149-54. Review.

PMID:
9749587
4.

Atypical parkinsonism in the Caribbean island of Guadeloupe: etiological role of the mitochondrial complex I inhibitor annonacin.

Lannuzel A, Ruberg M, Michel PP.

Mov Disord. 2008 Nov 15;23(15):2122-8. doi: 10.1002/mds.22300. Review.

PMID:
18816693
5.

Exercise alleviates Parkinsonism: clinical and laboratory evidence.

Archer T, Fredriksson A, Johansson B.

Acta Neurol Scand. 2011 Feb;123(2):73-84. doi: 10.1111/j.1600-0404.2010.01360.x. Review.

PMID:
21108623
6.

[Treatment of Parkinsonism: collaboration between the physician and the neurologist].

Vingerhoets F.

Rev Med Suisse Romande. 2000 Sep;120(9):709-16. Review. French. No abstract available.

PMID:
11094535
Items per page

Supplemental Content

Write to the Help Desk